104 related articles for article (PubMed ID: 19416257)
21. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe.
Lacour JP; Ulrich C; Gilaberte Y; Von Felbert V; Basset-Seguin N; Dreno B; Girard C; Redondo P; Serra-Guillen C; Synnerstad I; Tarstedt M; Tsianakas A; Venema AW; Kelleners-Smeets N; Adamski H; Perez-Garcia B; Gerritsen MJ; Leclerc S; Kerrouche N; Szeimies RM
J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2342-8. PubMed ID: 26435363
[TBL] [Abstract][Full Text] [Related]
22. A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½ h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp.
Wiegell SR; Fabricius S; Stender IM; Berne B; Kroon S; Andersen BL; Mørk C; Sandberg C; Jemec GB; Mogensen M; Brocks KM; Philipsen PA; Heydenreich J; Haedersdal M; Wulf HC
Br J Dermatol; 2011 May; 164(5):1083-90. PubMed ID: 21219287
[TBL] [Abstract][Full Text] [Related]
23. Daylight versus conventional photodynamic therapy for the treatment of actinic keratosis: A meta-analysis of randomized controlled trials.
Mei X; Wang L; Zhang R; Zhong S
Photodiagnosis Photodyn Ther; 2019 Mar; 25():23-28. PubMed ID: 30412779
[TBL] [Abstract][Full Text] [Related]
24. The use of photodynamic therapy in medical practice.
Aebisher D; Rogóż K; Myśliwiec A; Dynarowicz K; Wiench R; Cieślar G; Kawczyk-Krupka A; Bartusik-Aebisher D
Front Oncol; 2024; 14():1373263. PubMed ID: 38803535
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous Squamous Cell Carcinoma: An Updated Review.
Jiang R; Fritz M; Que SKT
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791879
[TBL] [Abstract][Full Text] [Related]
26. Digitally Enhanced Methods for the Diagnosis and Monitoring of Treatment Responses in Actinic Keratoses: A New Avenue in Personalized Skin Care.
Soare C; Cozma EC; Celarel AM; Rosca AM; Lupu M; Voiculescu VM
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339236
[TBL] [Abstract][Full Text] [Related]
27. Is a 4 J/cm
Fronville M; Creusot M; Mordon SR
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895925
[No Abstract] [Full Text] [Related]
28. Advanced Light Source Technologies for Photodynamic Therapy of Skin Cancer Lesions.
Algorri JF; López-Higuera JM; Rodríguez-Cobo L; Cobo A
Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631289
[TBL] [Abstract][Full Text] [Related]
29. Equivalent efficacy of indoor daylight and lamp-based 5-aminolevulinic acid photodynamic therapy for treatment of actinic keratosis.
Ruiz AJ; LaRochelle EPM; Fahrner MP; Emond JA; Samkoe KS; Pogue BW; Chapman MS
Skin Health Dis; 2023 Aug; 3(4):e226. PubMed ID: 37538332
[TBL] [Abstract][Full Text] [Related]
30. Understanding the Photodynamic Therapy Induced Bystander and Abscopal Effects: A Review.
Moloudi K; Sarbadhikary P; Abrahamse H; George BP
Antioxidants (Basel); 2023 Jul; 12(7):. PubMed ID: 37507972
[TBL] [Abstract][Full Text] [Related]
31. The Role and Effectiveness of Photodynamic Therapy on Patients With Actinic Keratosis: A Systematic Review and Meta-Analysis.
Mpourazanis G; Konschake W; Vogiatzis R; Papalexis P; Georgakopoulou VE; Ntritsos G; Sklapani P; Trakas N
Cureus; 2022 Jun; 14(6):e26390. PubMed ID: 35911353
[TBL] [Abstract][Full Text] [Related]
32. Randomized Clinical Trial of Conventional versus Indoor Daylight Photodynamic Therapy for Treatment of Actinic Cheilitis.
Arisi M; Galli B; Pisani EG; La Rosa G; Licata G; Rovaris S; Tomasi C; Rossi M; Venturini M; Spiazzi L; Calzavara-Pinton P
Dermatol Ther (Heidelb); 2022 Sep; 12(9):2049-2061. PubMed ID: 35907163
[TBL] [Abstract][Full Text] [Related]
33. A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions.
Del Regno L; Catapano S; Di Stefani A; Cappilli S; Peris K
Am J Clin Dermatol; 2022 May; 23(3):339-352. PubMed ID: 35182332
[TBL] [Abstract][Full Text] [Related]
34. How Much Protoporphyrin IX Must Be Activated to Obtain Full Efficacy of Methyl Aminolevulinate Photodynamic Therapy? Implication for Treatment Modifications.
Wulf HC; Heerfordt IM; Philipsen PA
Pharmaceuticals (Basel); 2021 Apr; 14(4):. PubMed ID: 33917339
[TBL] [Abstract][Full Text] [Related]
35. Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives.
Lee SY; Kim CY; Nam TG
Drug Des Devel Ther; 2020; 14():5375-5392. PubMed ID: 33299303
[TBL] [Abstract][Full Text] [Related]
36. Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.
Gutzmer R; Wiegand S; Kölbl O; Wermker K; Heppt M; Berking C
Dtsch Arztebl Int; 2019 Sep; 116(37):616-626. PubMed ID: 32048593
[TBL] [Abstract][Full Text] [Related]
37. Weather-informed Light-tissue Model-Based Dose Planning for Indoor Daylight Photodynamic Therapy.
LaRochelle EPM; Chapman MS; Maytin EV; Hasan T; Pogue BW
Photochem Photobiol; 2020 Mar; 96(2):320-326. PubMed ID: 31581341
[TBL] [Abstract][Full Text] [Related]
38. Measuring Daylight: A Review of Dosimetry in Daylight Photodynamic Therapy.
O'Mahoney P; Khazova M; Eadie E; Ibbotson S
Pharmaceuticals (Basel); 2019 Sep; 12(4):. PubMed ID: 31547141
[TBL] [Abstract][Full Text] [Related]
39. Clinical utility of daylight photodynamic therapy in the treatment of actinic keratosis - a review of the literature.
Nguyen M; Sandhu SS; Sivamani RK
Clin Cosmet Investig Dermatol; 2019; 12():427-435. PubMed ID: 31239746
[TBL] [Abstract][Full Text] [Related]
40. A New Light-Emitting, Fabric-Based Device for Photodynamic Therapy of Actinic Keratosis: Protocol for a Randomized, Controlled, Multicenter, Intra-Individual, Phase II Noninferiority Study (the Phosistos Study).
Vignion-Dewalle AS; Abi Rached H; Thecua E; Lecomte F; Deleporte P; Béhal H; Hommel T; Duhamel A; Szeimies RM; Mortier L; Mordon S
JMIR Res Protoc; 2019 Apr; 8(4):e12990. PubMed ID: 31025953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
